secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2022-02-07T23:59:59+00:00
Accession:  0001558370-22-000862
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine terminates CMO Lisa Michaels effective immediately
------------------------------------------------------------------

- Lisa Michaels' employment as Chief Medical Officer terminated on February 7, 2022.
- Severance includes base salary for 12 months, COBRA contributions, and unpaid prior bonus.
- Payments contingent on signing and compliance with severance and release agreement.
- No successor appointed; CEO James Mullen signed the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000155837022000862/0001558370-22-000862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000155837022000862/edit-20220207x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-000862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer